News
Andy Vélez, a seminal New York AIDS and Latino Queer activist dies at 80
His advocacy work improved drug access and civil rights for people living with HIV
Andy Vélez, an internationally prominent AIDS activist, whose three decades of advocacy work resulted in improved drug access and civil rights for people living with HIV, especially in the Latino community, died on May 14, 2019 at Mt. Sinai Beth Israel Hospital in Manhattan. He was 80.
His sons Ben and Abe Vélez said the cause of death was complications arising from a severe fall in his Greenwich Village building in April.
Until his recent accident and despite several health challenges, Vélez had remained consistently active in the AIDS and social justice communities, taking part in protests for ACT UP and Rise and Resist. Vélez was a seminal member of ACT UP, joining the group in 1987, its first year of activity, and played a prominent role in its most notorious demonstrations over the past 32 years.
Vélez was born on March 9, 1939 in the Bronx to Ramon Vélez and the former Dorothy Solomon. The family, including siblings Eugene and Raymond (“Al”), soon relocated to Aguadilla, Puerto Rico, where they lived a few years before returning to the Bronx. Vélez graduated from William Howard Taft High School in 1955 at age 16. He attended City College for a brief time, but interrupted his studies when he left home. Years later, after attending night school, Vélez would formally graduate.
Vélez earned a Master’s degree in psychoanalysis in 1976 and worked with the Center for Modern Psychoanalytic Studies under Dr. Phyllis Meadow in the Village. He maintained his own therapy practice for two decades. Vélez had initially explored psychoanalysis for personal reasons, suspecting that he was homosexual. In 1964, he was entrapped by an undercover policeman in a Park Avenue South bar. Vélez spent the night in the jail facility known as The Tombs, a traumatizing experience that would provide the impetus for his activism. Vélez lost his position at the Housing Authority when his boss learned of his arrest. He received a suspended sentence of six months. But when Vélez pushed back legally with the help of a progressive lawyer, his conviction was later reversed.
While he initially hoped to become an actor, and appeared in several off-Broadway productions in the late 1950s and early 1960s, Vélez found success in other careers. He entered book publishing in 1969. Over the course of 16 years he worked his way up to the position of president of the prominent Frederick Ungar Publishing, managing the company until it was sold in 1985. Notable among his literary projects was a 1984 collaboration with screen star Marlene Dietrich to update her 1962 bestseller Marlene Dietrich’s ABC.
Once he was divorced, Vélez began to make active connections with the LGBTQ community. He served as a leader for the Gay Circles Consciousness Raising Group for almost three years. One evening, after his group ended, Vélez walked past the first meeting of a new organization dedicated to addressing government inaction surrounding HIV/AIDS. He was intrigued.
The group soon had a name: ACT UP, the AIDS Coalition to Unleash Power. Vélez became involved in several ACT UP committees, including the Media Committee and Actions Committee. He was involved in high-profile demonstrations and civil disobedience arrest scenarios that showcased ACT UP’s signature street theatre activism, such as chaining himself in the office of a pharmaceutical company, or covering himself in fake blood to symbolize the lives lost to AIDS because of government negligence.
However, Vélez found his niche with the group’s Latino Caucus, which focused on the raging but neglected epidemic in the Latino community. Significantly, Vélez and his colleagues traveled to Puerto Rico to help organize a local ACT UP chapter in the commonwealth. He was also a founding member of Queer Nation in New York City in 1990.
He was involved in many AIDS educational and service organizations over the years, serving as an administrator and bilingual educator for AIDSMEDS.com for more than a decade. His writing and activism intersected significantly when he moderated a community forum on AIDSMeds.com, where he directed desperate people to lifesaving medical information. Vélez also wrote about the epidemic for numerous community publications, including POZ, Body Positive, and SIDA Ahora. For ten years he moderated the POZ Forum. He took part in aggressive and effective treatment access work with Treatment Action Group, and worked in a New York City HIV clinical trial unit, alerting affected communities to their vulnerability to tuberculosis.
From the 1990s through the 2010s, Vélez returned to his first love of theater by covering the scene for several LGBT magazines, as well as by conducting interviews with jazz greats for All About Jazz and the New York City Jazz Record. He penned liner notes for the CD reissues of several Broadway musical classics, such as Finian’s Rainbow, The Pajama Game, and Saratoga. He also provided liner notes for vocal collections by legends such as Doris Day, Fred Astaire, Ella Fitzgerald, and Artie Shaw. From 1990 to 1992, he taught courses in musical theater at the New School. Among his in-class guests from the golden age of Broadway: Barbara Cook, Sheldon Harnick, Elaine Stritch, John Kander and Fred Ebb. He was included in the anthology Cast Out: Queer Lives in the Theater, a collection focusing on out lesbians and gays currently working on the American stage.
Vélez became a prominent presence on the international AIDS scene for more than two decades, working with co-organizers of the International Conference on AIDS to guarantee the inclusion and active participation of people with HIV. He also served for several conferences as the official liaison to the activist community. He served as a consultant to the Latino Commission on AIDS, and was a guest speaker on HIV/AIDS issues at high schools and colleges across America.
Years ago, when asked how he would like to be remembered, Vélez replied, “As someone who was able to help.”
Andy Vélez is survived by his sons Ben and Abe, both of Brooklyn, his daughter-in-law Sarah, his granddaughter, his younger brother Eugene (“Gene’) of Alamo, California, as well as thousands of comrades in the global AIDS and LGBTQ activist communities.
Funeral services will be private. A public memorial service will be held this summer.
Donations in Vélez’s memory may be made to ACT UP New York, Broadway Cares/Equity Fights AIDS, and the Latino Commission on AIDS.
Andy Vélez, presente y pa’lante!
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Rehoboth Beach
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
$4.5 million listing includes real estate; business sold separately
Gay gasps could be heard around the DMV earlier this week when a real estate listing for Rehoboth Beach’s iconic Blue Moon bar and restaurant hit social media.
Take a breath. The Moon is for sale but the longtime owners are not in a hurry and are committed to preserving its legacy as a gay-friendly space.
“We had no idea the interest this would create,” Tim Ragan, one of the owners, told the Blade this week. “I guess I was a little naive about that.”
Ragan explained that he and longtime partner Randy Haney are separating the real estate from the business. The two buildings associated with the sale are listed by Carrie Lingo at 35 Baltimore Ave., and include an apartment, the front restaurant (6,600 square feet with three floors and a basement), and a secondary building (roughly 1,800 square feet on two floors). They are listed for $4.5 million.
The bar and restaurant business is being sold separately; the price has not been publicly disclosed.
But Ragan, who has owned the Moon for 20 years, told the Blade nothing is imminent and that the Moon remains open through the holidays and is scheduled to reopen for the 2026 season on Feb. 10. He has already scheduled some 2026 entertainment.
“It’s time to look for the next people who can continue the history of the Moon and cultivate the next chapter,” Ragan said, noting that he turns 70 next year. “We’re not panicked; we separated the building from the business. Some buyers can’t afford both.”
He said there have been many inquiries and they’ve considered some offers but nothing is firm yet.
Given the Moon’s pioneering role in queering Rehoboth Beach since its debut 44 years ago in 1981, many LGBTQ visitors and residents are concerned about losing such an iconic queer space to redevelopment or chain ownership.
“That’s the No. 1 consideration,” Ragan said, “preserving a commitment to the gay community and honoring its history. The legacy needs to continue.” He added that they are not inclined to sell to one of the local restaurant chains.
You can view the real estate listing here.
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
Why queer spaces often fail South Asian women
